Sherryl saw her oncologist on Monday and began a new chemotherapy today. Docetaxel will be administered intravenously once a week for three weeks, then there will be no chemo on the fourth week. The other news Sherryl received is that her tumor marker is 553. This high number does not come as a surprise because chemotherapy is suspended during radiation treatment, so Sherryl has had no chemotherapy since before she was in the hospital. Once radiation was completed, Sherryl's oncologist needed to determine if Gemzar should be resumed or not; the decision was to try another therapy.
Sherryl's oncologist explained that, although there is "a lot of disease in the bone," it is not overtaking her the body and it has not spread to any organs. He explained some of the side effects of the new drug, many of which are similar to side effects Sherryl experienced on the first chemotherapy.
After her first dose today, Sherryl says she feels tired, but it's a good tired. She has returned to day care and continues to slowly but surely push herself in order to optimize her strength.
Special thanks to those who continue to send to RaRa prayers, good thoughts, and hopes for good health. We so appreciate every thought and every gesture you express for our sister.